Skip to content

IMRN

Immuron Ltd.

NASDAQ · Healthcare · Biotechnology · AU

$0.88
−4.60%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
1.08x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
0.91x
Price / sales
1.33x
Price / cash flow
-3.36x

Enterprise value

Enterprise value
$739.4K
EV / sales
0.14x
EV / EBITDA
-0.23x
EV / EBIT
-0.23x
Market cap
$7.1M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026